SUCCESSFUL USE OF RECOMBINANT FACTOR VIIa IN PATIENT WITH SEVERE HAEMOPHILIA A DURING SYNOVECTOMY-Reference-Cited by-同舟云学术

SUCCESSFUL USE OF RECOMBINANT FACTOR VIIa IN PATIENT WITH SEVERE HAEMOPHILIA A DURING SYNOVECTOMY

Published:1988-11 Issue:8621 Volume:332 Page:1193
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Hedner U.,Glazer S.,Pingel K.,Alberts K.A.,Blombäck M.,Schulman S.,Johnsson H.

Publisher

Elsevier BV

Subject

General Medicine

Reference8 articles.

1. The effect of activated prothrombin-complex concentrate (FEIBA) on joint and muscle bleeding in patients with hemophilia A and antibodies to factor VIII a double-blind clinical trial;Sjamsoedin;N Engl J Med,1981

2. Prothrombm complex concentrates Potentially thrombogenic materials and clues to the mechanism of thrombosis in vivo;White;Blood,1977

3. Use of human factor VIIa in treatment of two hemophilia A patients with high titer inhibitors;Hedner;J Clin Invest,1983

4. Comparison of the effect of factor VII prepared from human (pVIIa) and recombinant VIIa (rVIIa) in vitro and in rabbits;Hedner;Thrombos Haemostas,1987

5. Human factor VII;Broze;Methods Enzymol,1981

Cited by 213 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical, Laboratory, and Molecular Aspects of Factor VII Deficiency;Seminars in Thrombosis and Hemostasis;2024-08-29

2. Congenital Factor VII Deficiency, Diagnosis, and Management;Congenital Bleeding Disorders;2023

3. Inhibitors in Hemophilia A;Advances in Hemophilia Treatment;2022

4. The safety of activated eptacog beta in the management of bleeding episodes and perioperative haemostasis in adult and paediatric haemophilia patients with inhibitors;Haemophilia;2021-10-11

5. Factor VIIa is not just a factor X activator;Blood;2021-06-17